Profile
Oliver Dick is currently the Chief Operating Officer at Resolve BioSciences GmbH since 2021.
Prior to this, he worked as the Chief Operating Officer at Miltenyi Biotec Norden AB.
Oliver Dick active positions
| Companies | Position | Start |
|---|---|---|
Resolve BioSciences GmbH
 Resolve BioSciences GmbH BiotechnologyHealth Technology Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023. | Chief Operating Officer | 2021-11-30 |
Former positions of Oliver Dick
| Companies | Position | End |
|---|---|---|
| Miltenyi Biotec Norden AB | Chief Operating Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
| Miltenyi Biotec Norden AB | |
Resolve BioSciences GmbH
Resolve BioSciences GmbH BiotechnologyHealth Technology Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023. | Health Technology |
- Stock Market
- Insiders
- Oliver Dick
